Nag. Coad et al., ANALYSIS OF PLOIDY AND PROLIFERATIVE ACTIVITY IN CHILDHOOD NON-HODGKINS-LYMPHOMA (NHL) AND HODGKINS-DISEASE (HD), PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 17(6), 1997, pp. 893-902
We have performed DNA analysis by means of fluorescence-activated cell
cytometry on paraffin-embedded tissue from the diagnostic biopsy spec
imens in 40 cases of non-Hodgkin's lymphoma (NHL) and 25 of Hodgkin's
disease (HD) and from 50 normal tonsils as controls. For HD cases, ane
uploidy was found in 7 of 25 (28%), a higher proportion than in two pr
evious studies of mainly adult patients. Diploid tumors showed S-phase
fractions (SPFs) similar to those of controls. In the NHL cases aneup
loidy was found in 12 of 40 (30%) with no significant association with
site, stage, histopathology, immunophenotype, or prognosis. SPFs were
highest in abdominal and chest primary sites but were not related to
stage. Burkitt's lymphomas had the highest SPFs relative to lymphoblas
tic (P < .01) and centroblastic lymphomas (P < .05). Significantly hig
her SPFs were found in B cell than in T cell tumors (P < .001). There
was considerable heterogeneity for SPFs within each NHL subgroup. Surv
ival was worse at 5 years for those with high SPFs compared with those
with normal SPFs (P = .04). These results suggest that tumor DNA anal
ysis maybe useful in the evaluation of children with NHL. Larger studi
es are needed to define its role as an independent prognostic variable
.